drugset / Trial / NCT01093807
Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of various dosage combinations of lercanidipine (10 and 20 mg)and enalapril (10 and 20 mg) in comparison with their respective components and with placebo.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-03
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enalapril | Other / unclassified | 10 mg | — |
| Subject | Enalapril | Other / unclassified | 20 mg | — |
| Subject | Lercanidipine | Small molecule | 10 mg | — |
| Subject | Lercanidipine | Small molecule | 20 mg | — |